ReviewFrontiers in neurology2020

Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective.

Yannick Vermeiren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.